May 28, 2025, 11:58 | Blog

Francisco Esteva: Learn about PI3K Pathway Inhibitors in HR+ Metastatic Breast Cancer

Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital…

May 26, 2025, 15:28 | Blog

ESMO Guidelines: Real World Cases - Webinar Series: Metastatic Breast Cancer 2025

ESMO shared a post on X: "Stay up to date with the latest evidence-based recommendations…

May 20, 2025, 10:09 | Blog

Antonio Giordano: Benefit of CDK4/6i in HER2+ MBC

Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X: "More evidence…

May 17, 2025, 17:38 | Science

Chiara Corti: Decoding Clinical Trials in Metastatic Breast Cancer - Practical Insights for Optimal Therapy Sequencing

Chiara Corti, Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "NEW…

May 17, 2025, 15:23 | Oncolibrary

SGNTUC-019 Trial Final Results: Tucatinib + Trastuzumab Shows Durable Benefit in HER2-Mutant MBC at ESMO 2025

The final analysis of the SGNTUC-019 trial Phase II basket trial provides compelling evidence that…

May 16, 2025, 08:41 | Blog

Elvina Almuradova: Treatment Algorithm For HER+/HER2- Metastatic Breast Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

May 15, 2025, 14:51 | Blog

Pablo Mando: T-DXd demonstrated benefit over Capecitabine and Taxane in HR+/HER2- MBC

Pablo Mando, Editor-in-Chief of Oncologia Clínica, shared a post on X: "Great presentation by Carlos Barrios…

May 15, 2025, 11:36 | Blog

Amol Akhade: EMBER-3 Trial Results in ER+/HER2- Metastatic Breast Cancer

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared…

May 13, 2025, 22:39 | Blog

Paolo Tarantino: Cure is a word we rarely use in metastatic breast cancer

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Cure. A…

May 12, 2025, 09:16 | Science

Goutham Sunny: TILs may serve as valuable Prognostic Biomarkers in HER2+ mBC

Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, shared an article on X:…

May 7, 2025, 01:14 | Science

Integrative Strategies in Palliative Care for Metastatic Breast Cancer - ABC Global Alliance

ABC Global Alliance shared an article on LinkedIn: "New video alert! Join Dr. Fatima Cardoso, President…

May 6, 2025, 10:45 | Drugs

Amol Akhade: Oral SERDs and PROTACs in ER+/HER2– Metastatic Breast Cancer - Trial Landscape Update

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared…

Apr 24, 2025, 10:39 | Blog

Tanja Obradovic: Improved PFS versus current SOC of taxane, trastuzumab and pertuzumab

Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON PLCh, shared a post on LinkedIn:…

Apr 23, 2025, 08:55 | Blog

Ahmed Alanazi: ADCs are now reshaping the standard of care for metastatic Breast Cancer

Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X: "ADCs…

Apr 21, 2025, 10:45 | Blog

Kristina Jankovic: DESTINY-Breast09 - Enhertu plus Pertuzumab Tops THP in 1L HER2+ metastatic breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:…

Apr 21, 2025, 08:07 | Blog

Matthew Kurian: DESTINY-Breast09 may change the landscape of first-line treatment for HER2+ MBC

Matthew Kurian, Physician at St. Elizabeth Healthcare and Assistant Professor of Medicine at the University…

Apr 20, 2025, 19:09 | Science

Hope Rugo: Congratulations to Laura Huppert on the multicenter study of sequential ADC use in HER2-low MBC

Hope Rugo, Professor of Medicine at the University of California, San Francisco, shared a post…

Apr 19, 2025, 18:29 | Insight

ESMO living guidelines on metastatic breast cancer

European Society for Medical Oncology (ESMO) shared a post on X: "ESMO Living Guidelines on…

Mar 25, 2025, 18:59 | Blog

Evandro de Azambuja: Attending the first French-Belgian meeting for patients with metastatic breast cancer

Evandro de Azambuja, BSMO President 2023-2026, shared a post on LinkedIn: "Some members of the…

Mar 9, 2025, 15:01 | Blog

Sami Mansfield: Racial disparities in recommending PI3K inhibitors in black women with mBC

Sami Mansfield, Founder of Cancer Wellness for Life, shared a post on LinkedIn: "New study…

Mar 3, 2025, 11:36 | Insight

Racial Disparities in ctDNA Profiles and Targeted Therapy in mBC - International Society of Liquid Biopsy

International Society of Liquid Biopsy (ISLB) shared a post on X about a paper by…

Feb 20, 2025, 09:40 | Science

Mihaela Stana: The spectrum of adverse events during mBC treatment with ADCs

Mihaela Stana, Oncology Specialist at Elysee Hospital, shared a post on LinkedIn about a paper…

Feb 18, 2025, 16:33 | Blog

Elene Kekelia: First Young Doctors’ Conference on Metastatic Breast Cancer in Georgia

Elene Kekelia, University Lecturer at Petre Shotadze Tbilisi Medical Academy (TMA), shared a post on…

Feb 11, 2025, 10:28 | Blog

Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Back…

Feb 11, 2025, 08:06 | Blog

The Evolving Role of Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer - International Society of Liquid Biopsy

International Society of Liquid Biopsy shared a post on X: "ISLB-Endorsed Seminar: The Evolving Role…

Feb 9, 2025, 15:15 | Science

Elvina Almuradova: Survival outcomes for ERBB2-positive MBC patients with brain metastases

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 3, 2025, 14:40 | Blog

Paolo Tarantino: Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, posted on X about recent paper…

Jan 30, 2025, 08:44 | Science

Final analysis of the PRECIOUS phase 3 trial

Paolo Tarantino, Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared an article by…

Jan 23, 2025, 14:32 | Blog

Exciting progress in metastatic breast cancer research - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared the following on X: “Exciting progress in Metastatic Breast Cancer…

Jan 21, 2025, 06:43 | Blog

SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond

SPCC (Sharing Progress in Cancer Care) shared the following on LinkedIn: “HR+/HER2- MBC treatment landscape:…

Jan 19, 2025, 13:52 | Insight

Amol Akhade: Datopotomab deruxtecan got approved for HR+ HER2- MBC in the third line

Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on…

Jan 17, 2025, 14:35 | Science

Elisa Agostinetto: The Preferable-Effect trial is now out

Elisa Agostinetto, Medical Oncologist at the Brussels University Hospital, posted on X, about recent paper…

Jan 15, 2025, 13:54 | Blog

FDA Fast Tracks Emiltatug Ledadotin in Advanced or Metastatic Breast Cancer

The FDA granted a new fast track designation to emiltatug ledadotin for the treatment of…

Jan 13, 2025, 19:41 | Blog

Professor Gianluca Franceschini: Advancing Breast Cancer Surgery - Mediamedic

Mediamedic shared a post on LinkedIn: "Professor Gianluca Franceschini: Advancing Breast Cancer Surgery. We are…

Jan 13, 2025, 13:04 | Blog

Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC

Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be…

Jan 13, 2025, 10:23 | Science

The Randomized Noninferiority Phase III EMERALD Trial on HER2+ Locally Advanced/Metastatic Breast Cancer

A recent paper by Toshinari Yamashita et al. was published in the Journal of Clinical…

Jan 10, 2025, 14:23 | Insight

Janice Cowden: Accurate counting and research funding for metastatic breast cancer

Janice Cowden, Former nurse, Cancer patient and Advocate, shared a post on X by Ann…

Jan 7, 2025, 17:29 | Science

Nicolas Hart: Assessing cognitive function in metastatic breast cancer survivors

Nicolas Hart, Associate Professor at the National Health and Medical Research Council, shared a post…

Dec 27, 2024, 13:51 | Insight

Arvinas has joined Metastatic Breast Cancer Alliance as an Industry Member

Metastatic Breast Cancer Alliance shared a post on LinkedIn: “ICYMI: Arvinas joined us as an…

Dec 20, 2024, 17:25 | Blog

Our PCORI-funded CDK study has officially enrolled its first patient at Ironwood Cancer Center - ASCO

ASCO made the following post on X: “Exciting news! Our PCORI-funded CDK study has officially…

Dec 20, 2024, 17:18 | Blog

Julia Maués' SABCS 2024 highlights - Breast Cancer Research Foundation

Breast Cancer Research Foundation shared the following on X: “Last week, we were on the…

Dec 18, 2024, 11:33 | Blog

Sally Wolf: Full Circle Moments Remind Us to Reflect

Sally Wolf, CEO and Founder of LightWorks, shared a post on LinkedIn: “Full circle moments…

Dec 16, 2024, 08:20 | Blog

Francisco J. Esteva: Addressing gaps in real-world oncology care through data studies

Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…

Dec 15, 2024, 10:54 | Blog

Elvina Almuradova: EMBER-3 trial highlights imlunestrant for metastatic breast cancer

Elvina Almuradova, Associate Professor at Medicana Health Group, posted the following on LinkedIn: “The EMBER-3 trial…

Dec 15, 2024, 09:42 | Insight

Lisa Carey and Otto Metzger, discuss about the phase 3 PATINA trial

SABCS shared a post on X: “Now on SABCS Snippets: Lisa Carey and Otto Metzger,…

Dec 15, 2024, 01:17 | Blog

Amol Akhade: How to treat metastatic breast cancer at the end of 2024

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals,…

Dec 14, 2024, 06:34 | Blog

Immediate Subsequent lines of therapy after T-DXd in Metastatic Breast Cancer - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "SABCS24 POSTER SESSION | P1-08-08 |…

Dec 2, 2024, 13:48 | Blog

Janice Cowden: Excited to share that I’ve been invited to serve as a social media ambassador at SABCS 2024

Janice Cowden, Former nurse, Cancer patient and Advocate, shared a post on LinkedIn by OncoDaily,…

Nov 16, 2024, 09:57 | Blog

Targeting expression in metastatic breast cancer - ASCO

ASCO posted the following on X: “Though ADCs have emerged as a cutting-edge approach to…

Nov 9, 2024, 20:45 | Blog

Sophie Blake: Honoured to be included in the Top 100 list of X Influencers in Breast Cancer by OncoDaily

Sophie Blake shared a post on X: "I am honoured to be included in the Top…

Nov 8, 2024, 19:01 | Insight

Predictors of Response to CDK4/6i Rechallenge in ER+ Metastatic Breast Cancer

Sergio Cifuentes Canaval, Medical Oncology Fellow at National Autonomous University of Mexico, shared a post…

Nov 5, 2024, 15:32 | Blog

Carmen Criscitiello: SERENA-2 and INAVO120 offering fresh insights on targeted approaches in MBC

Carmen Criscitiello, Medical Oncologist at IEO and Associate Professor at University of Milan, posted on…

Nov 5, 2024, 00:59 | Blog

Ginny Mason: Remembering all the inflammatory and metastatic breast cancer souls I've known in the 30 years since my own diagnosis

Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on…

Nov 3, 2024, 16:25 | Blog

Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance

ABC Global Alliance shared the following on LinkedIn: “Did you know 56% of patients didn’t…

Nov 2, 2024, 03:33 | Blog

More and more women are living longer with metastatic breast cancer - Africa Cancer Foundation

Africa Cancer Foundation shared the following on X: "More and more women are living longer…

Nov 1, 2024, 14:35 | Blog

Francisco J. Esteva: The standard of care for hormone receptor-positive, HER2-negative metastatic breast cancer

Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a post on…

Oct 31, 2024, 17:16 | Blog

Monica Steigerwald: Gilead Sciences announced its amazing allocation of $3.15 million to 22 organizations

Janice Cowden, Former nurse, cancer patient and advocate, shared a post by Monica Steigerwald, Vice President…

Oct 31, 2024, 10:10 | Insight

Evaluating the Efficacy of Scalp Cooling on Hair Loss in Patients with Metastatic Breast Cancer: A Phase II Clinical Trial

We are pleased to announce the enrollment of participants for a pivotal Phase II clinical…

Oct 31, 2024, 08:59 | Insight

Self-directed online psychosocial intervention for women with metastatic breast cancer - MASCC

Multinational Association of Supportive Care in Cancer (MASCC) shared a post on X about a recent paper…

Oct 30, 2024, 19:17 | Blog

Ginny Mason: When is SEER going to start counting and keeping tabs on breast cancer patients?

Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post by Living…

Oct 25, 2024, 09:05 | Dialogues

ASCO24 Updates: Dr. Xin Hu on Early Palliative Care in Advanced Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 24, 2024, 16:10 | Blog

Lisa Beatty: Digital Mental Health Intervention for women with Metastatic Breast Cancer

Lisa Beatty, Associate Professor in Clinical Psychology at Flinders University, shared on X: "Its Breast…

Oct 19, 2024, 10:51 | Blog

Tracey O'Brien: Our state is the first jurisdiction in the world to accurately determine people living with metastatic breast cancer

Tracey O'Brien shared a post on LinkedIn: "Making sure people with cancer are seen and heard…

Oct 14, 2024, 11:50 | Blog

Sally Wolf: Pure pink doesn't include metastatic breast cancer

Sally Wolf, CEO and Founder, LightWorks, shared a post on LinkedIn: "If you loved the…

Oct 13, 2024, 12:08 | Blog

National Metastatic Breast Cancer Awareness Day 2024

National Metastatic Breast Cancer Awareness Day is celebrated on October 13th to shed light on…

Oct 12, 2024, 11:21 | Insight

How to determine optimal treatment for de novo metastatic breast cancer

Fumiko Ladd Chino shared a post on X: "Dr Jennifer Plichta, Duke Cancer Breast Surgical Oncology…

Oct 10, 2024, 16:44 | Blog

Giuseppe Curigliano: With T-DXd for HR-Positive Metastatic Breast Cancer

Giuseppe Curigliano shared an article on X: "DESTINY-Breast06 Shows Significant PFS Improvement With T-DXd for HR-Positive…

Oct 8, 2024, 12:41 | Blog

The Ending Metastatic Breast Cancer for Everyone Program - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared on X: "Join Kristina Fanucci, MD, and Antonio Giordano, MD, PhD,…

Oct 6, 2024, 14:01 | Insight

MD Anderson Research Highlights

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Oct 6, 2024, 10:34 | Blog

Vicki Durston: Enhancing outcomes for individuals diagnosed and living with Metastatic Breast Cancer

Vicki Durston shared on LinkedIn: "Coming to you from Lisbon, Portugal during Breast Cancer Awareness…

Oct 4, 2024, 10:15 | Blog

The first prospective trial of sacituzimab govitecan (+ trastuzumab) after T-DXd for HER2+ MBC

Paolo Tarantino shared a post by Dana-Farber’s Breast Oncology Center on X, adding: "There’s few open questions as…

Sep 30, 2024, 17:12 | Blog

Delving into the Latest Advancements in Metastatic Breast Cancer - The Breast Cancer Research Foundation

The Breast Cancer Research Foundation posted the following on LinkedIn: “With Metastatic Breast Cancer Awareness…

Sep 28, 2024, 14:00 | Blog

Paolo Tarantino: How do the results of DESTINY-Breast06 change our practice?

Paolo Tarantino shared on LinkedIn: "How do the results of DESTINY-Breast06 change our practice? Should…

Sep 26, 2024, 15:04 | Insight

Stephanie Graff: Ever wondered what 'clinically meaningful' really means

Stephanie Graff shared a post on X: "Ever wondered what 'clinically meaningful' really means? We sought…

Sep 23, 2024, 14:23 | Insight

Stephanie Graff: What ‘clinically meaningful’ actually means

Stephanie Graff shared on LinkedIn: “We have all heard the phrase ‘clinically meaningful’ from the…

Sep 16, 2024, 04:57 | Blog

The latest insights on ADCs for HR-Positive, HER2-low metastatic breast cancer - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: ''Paolo Tarantino will discuss the latest…

Sep 14, 2024, 06:02 | Blog

Emad Shash: Excited to share our three poster abstracts accepted for presentation at ESMO Congress 2024!

Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at…

Sep 10, 2024, 13:50 | Blog

Francisco J. Esteva: The importance of improving ctDNA methodologies

Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…

Sep 9, 2024, 08:35 | Blog

Carmine Valenza: Our contribution regarding ESR1m, endocrine-responsive metastatic breast cancer

Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…

Sep 4, 2024, 06:49 | Insight

Vicki Durston: Sarah Lee flying the flag for the benefits of exercise in living well with MBC

Vicki Durston, President of the General Assembly and Board Member of ABC Global Alliance, shared…

Aug 27, 2024, 17:21 | Insight

Review of precision therapeutics and emerging strategies in HR+ MBC

Michelle DeMeo, Senior Program Manager at Dana-Farber Cancer Institute, shared on X: "Congratulations to Maxwell…

Aug 25, 2024, 13:11 | Insight

How do SDOHs impact access to care for metastatic breast cancer patients - ACCC

Association of Cancer Care Centers (ACCC) shared a post on LinkedIn: "How do social drivers…

Aug 25, 2024, 13:09 | Blog

Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials

Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…

Aug 23, 2024, 16:14 | Blog

Practice changing updates on Metastatic Breast Cancer with Dr. Nan Chen - University of Chicago Hematology

University of Chicago Hematology shared a post on X: "This Saturday and Sunday Dr. Nan Chen…

Aug 22, 2024, 12:17 | Insight

Jame Abraham: we need to have a better understanding of HER-2 ultra-low and how to define it

Jame Abraham shared on X: "New approval for TDXd for metastatic breast cancer with HER…

Aug 12, 2024, 14:01 | Blog

Vicki Durston: Survey for clinicians and individuals impacted by metastatic breast cancer

Vicki Durston, Strategic Advisor, Specialist Direct at Specialist Direct Ptv Ltd, shared a post on…

Aug 10, 2024, 13:12 | Insight

Piotr Wysocki: Supervised, structured and individualized exercise improves the quality of life for metastatic breast cancer patients

Piotr Wysocki recently shared on LinkedIn: "A recent study published in Nature Medicine, led by Anouk…

Aug 6, 2024, 07:06 | Blog

Janice Cowden: 15 minute survey for metastatic breast cancer

Janice Cowden shared a post by ABC Global Alliance, on LinkedIn, adding: ''Please, if you…

Aug 6, 2024, 02:02 | Insight

Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer

Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…

Aug 5, 2024, 17:35 | Blog

Sandy Cassanelli: Honored to have Eric Winer interview me for my work at breast friends fund

Sandy Cassanelli, the CEO of Greenough Packaging and Maintenance Supplies and Breast Friends Fund-Funding Research…

Aug 4, 2024, 23:45 | Stories

Abigail Johnston: To say that my anxiety is flaring is a bit of an understatement

Abigail Johnston,Director of Mentorship at Project LIFE MBC, shared on X: "Scanxiety... Tomorrow is my…

Jul 27, 2024, 11:23 | Insight

Anouk Hiensch: Exercise improves quality of life in patients with metastatic breast cancer

Anouk Hiensch, Assistant Professor at UMC Utrecht, shared a post on X about his recent…

Jul 10, 2024, 17:46 | Blog

Gary L. Thompson: Lesley Fallowfield exploring ways to enable clinicians and genetic counselors to discuss challenging topics

Gary L. Thompson, Board Chair of Side-Out Foundation, shared on X: “Day 208/262 of my…

Jul 8, 2024, 18:14 | Insight

Paolo Tarantino: What is HER2 « ultralow » breast cancer, and why should you care?

Paolo Tarantino shared on X: “What is HER2 « ultralow » breast cancer, and why…

Jul 8, 2024, 15:07 | Blog

To say that we are heartbroken about losing our dear Marlena Murphy is an understatement - PIK3CA Path Breakers

PIK3CA Path Breakers shared on X: “To say that we are heartbroken about losing our…

Jul 8, 2024, 12:44 | Insight

Tatiana Prowell: Another person with Metastatic Breast Cancer taken too soon

Tatiana Prowell shared a post on X: “I am so grateful that I had the…

Jun 26, 2024, 03:18 | Insight

Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD

Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…

Jun 25, 2024, 16:01 | Insight

Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology

Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…

Jun 19, 2024, 12:33 | Blog

Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers

Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…

Jun 15, 2024, 04:53 | Insight

Felipe Rodrigues: Excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells

Felipe Rodrigues, Postdoctoral Researcher at Rockefeller University, recently shared a post on X: "Beyond excited…